CBER Issues List of Planned Guidance for 2019

Drug Industry Daily
A A
CBER on Wednesday issued its list of guidance it expects to release in 2019, including final versions of several gene therapy drafts issued in 2018.

To View This Article:

Login

Subscribe To Drug Industry Daily